We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.01%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$13.4M
(-8.3%)
Cap. Flow
+$5.17M
Cap. Flow
% of AUM
3.49%
Top 10 Holdings %
Top 10 Hldgs %
33.04%
Holding
120
New
14
Increased
23
Reduced
48
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$3.37M |
| 2 |
UPH
UpHealth, Inc.
UPH
|
+$2.17M |
| 3 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$1.55M |
| 4 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.35M |
| 5 |
Journey Medical
DERM
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VG
Vonage Holdings Corporation
VG
|
+$2.56M |
| 2 |
ZIXI
Zix Corporation
ZIXI
|
+$1.63M |
| 3 |
Vericel Corp
VCEL
|
+$997K |
| 4 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
+$585K |
| 5 |
OptimizeRx
OPRX
|
+$557K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.58% |
| 2 | Technology | 18.56% |
| 3 | Industrials | 7.3% |
| 4 | Consumer Staples | 6.91% |
| 5 | Communication Services | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Idexx Laboratories
IDXX
$43.7B
| $7.12M | 4.8% |
10,805
-300
| -3% | -$188K |
|
|
2
OptimizeRx
OPRX
$150M
| $6.7M | 4.52% |
107,830
-7,350
| -6% | -$557K |
|
3
Natera
NTRA
$47B
| $5.62M | 3.8% |
60,200
-2,200
| -4% | -$228K |
|
4
NeoGenomics
NEO
$2.32B
| $5.31M | 3.58% |
155,550
-2,200
| -1% | -$86.2K |
|
5
Microsoft
MSFT
$3.81T
| $5.21M | 3.52% |
15,493
| – | – |
|
6
Veracyte
VCYT
$3.48B
| $5.1M | 3.44% |
123,730
-1,250
| -1% | -$55.2K |
|
7
Abbott
ABT
$195B
| $3.81M | 2.57% |
27,080
-500
| -2% | -$64K |
|
8
Eli Lilly
LLY
$1.05T
| $3.7M | 2.5% |
13,408
-300
| -2% | -$76.1K |
|
9
Pfizer
PFE
$159B
| $3.2M | 2.16% |
54,248
-50
| -0.1% | -$2.48K |
|
|
FPAY
10
DELISTED
FlexShopper
FPAY
| $3.17M | 2.14% |
1,350,440
-128,430
| -9% | -$332K |
|
11
Ooma
OOMA
$629M
| $3.08M | 2.08% |
150,425
-1,650
| -1% | -$33.6K |
|
12
Inuvo
INUV
$11.5M
| $3M | 2.03% |
566,693
+83,340
| +17% | +$534K |
|
13
Digi International
DGII
$2.88B
| $2.98M | 2.01% |
121,250
-5,050
| -4% | -$116K |
|
|
ASPU
14
DELISTED
ASPEN GROUP, INC.
ASPU
| $2.7M | 1.82% |
1,144,375
+823,125
| +256% | +$3.37M |
|
15
AtriCure
ATRC
$2.47B
| $2.67M | 1.8% |
38,350
| – | – |
|
16
CareDx
CDNA
$2.58B
| $2.62M | 1.77% |
57,692
-2,750
| -5% | -$144K |
|
17
Perion Network
PERI
$382M
| $2.6M | 1.75% |
108,051
-3,800
| -3% | -$92.7K |
|
18
Axogen
AXGN
$2.77B
| $2.6M | 1.75% |
277,190
+3,950
| +1% | +$47.4K |
|
|
STRM
19
DELISTED
Streamline Health Solutions
STRM
| $2.51M | 1.69% |
112,277
-14,086
| -11% | -$338K |
|
|
CSLT
20
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.36M | 1.59% |
1,532,000
-131,000
| -8% | -$216K |
|
|
CTLP
21
DELISTED
Cantaloupe
CTLP
| $2.34M | 1.58% |
263,225
-10,500
| -4% | -$104K |
|
22
Exagen
XGN
$179M
| $2.32M | 1.57% |
199,475
-6,755
| -3% | -$79.1K |
|
|
XLNX
23
DELISTED
Xilinx Inc
XLNX
| $2.12M | 1.43% |
10,000
-795
| -7% | -$157K |
|
24
LeMaitre Vascular
LMAT
$1.84B
| $2.11M | 1.42% |
42,000
-9,700
| -19% | -$502K |
|
|
UPH
25
DELISTED
UpHealth, Inc.
UPH
| $2.1M | 1.42% |
+93,945
| New | +$2.17M |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Perkins Capital Management held 120 positions worth $148M, down 8.3% from $162M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Perkins Capital Management deployed $5.17M of net new capital in Q4 2021, opening 14 new positions and adding to 23 existing holdings. Its largest new stake was UpHealth, Inc.: 93,945 shares worth $2.1M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 64% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Vericel Corp, an estimated $997K trimmed.
- Perkins Capital Management's largest Q4 2021 buy was UpHealth, Inc.: 93,945 shares worth $2.1M.
- Perkins Capital Management added most to ASPEN GROUP, INC. in Q4 2021, an estimated $3.37M increase.
- Perkins Capital Management's biggest Q4 2021 reduction was Vericel Corp, cutting an estimated $997K.
- Perkins Capital Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $2.56M.
- Perkins Capital Management's ten largest holdings make up 33% of its $148M portfolio in Q4 2021.
- Perkins Capital Management opened 14 new positions and closed 11 in Q4 2021.
- Perkins Capital Management's portfolio value fell 8.3% quarter-over-quarter to $148M.
Based on Perkins Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.